Across TCGA cell cohorts, ZBED6CL mutation is significantly associated with the RNA expression of many other genes, with 6 significant associations in total. SKIN shows the largest number of these associations.

The most reproducible ZBED6CL-associated genes across cancer lineages are LRIT2, RBMY1J, and MEIKIN. Each is linked with ZBED6CL in more than 1 cancer types. Because this analysis shows association rather than direction, both ZBED6CL-to-partner and partner-to-ZBED6CL results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ZBED6CL→partner) and Y-score (partner→ZBED6CL) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
SKIN	LRIT2 →	+0.029	+5.415	<.001	.004	3	1
SKIN	RBMY1J →	+0.006	+4.977	<.001	.007	3	1
SKIN	MEIKIN →	+0.019	+5.415	<.001	.004	3	1
SKIN	OR5V1 →	+0.016	+4.977	<.001	.007	3	1
BLOOD_Leukemia	OR51T1 →	+0.071	+4.922	<.001	.009	3	1
BLOOD_Leukemia	GSG1L2 →	+0.058	+5.969	<.001	.001	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 6 associations by consensus.

Exploration

ZBED6CL survival (RNA) · tumor vs normal (RNA) · all ZBED6CL data types